Annual report pursuant to Section 13 and 15(d)

EQUITY METHOD INVESTMENTS

v2.4.0.8
EQUITY METHOD INVESTMENTS
 12 Months Ended
Dec. 31, 2013
EQUITY METHOD INVESTMENTS [Abstract]  
EQUITY METHOD INVESTMENTS
EQUITY METHOD INVESTMENTS
Our consolidated net income includes our Company's proportionate share of the net income or loss of our equity method investees. When we record our proportionate share of net income, it increases equity income (loss) — net in our consolidated statements of income and our carrying value in that investment. Conversely, when we record our proportionate share of a net loss, it decreases equity income (loss) — net in our consolidated statements of income and our carrying value in that investment. The Company's proportionate share of the net income or loss of our equity method investees includes significant operating and nonoperating items recorded by our equity method investees. These items can have a significant impact on the amount of equity income (loss) — net in our consolidated statements of income and our carrying value in those investments. Refer to Note 17 for additional information related to significant operating and nonoperating items recorded by our equity method investees. The carrying values of our equity method investments are also impacted by our proportionate share of items impacting the equity investee's AOCI.
We eliminate from our financial results all significant intercompany transactions, including the intercompany portion of transactions with equity method investees.
The Company's equity method investments include our ownership interests in Coca-Cola FEMSA, Coca-Cola Hellenic and Coca-Cola Amatil. As of December 31, 2013, we owned 28 percent, 23 percent and 29 percent, respectively, of these companies' outstanding shares. As of December 31, 2013, our investment in our equity method investees in the aggregate exceeded our proportionate share of the net assets of these equity method investees by $2,202 million. This difference is not amortized.
A summary of financial information for our equity method investees in the aggregate is as follows (in millions):
Year Ended December 31,
2013

 
2012

 
2011

Net operating revenues
$
53,038

 
$
47,087

 
$
42,472

Cost of goods sold
32,377

 
28,821

 
26,271

Gross profit
$
20,661

 
$
18,266

 
$
16,201

Operating income
$
4,380

 
$
4,605

 
$
4,181

Consolidated net income
$
2,364

 
$
2,993

 
$
2,237

Less: Net income attributable to noncontrolling interests
62

 
89

 
99

Net income attributable to common shareowners
$
2,302

 
$
2,904

 
$
2,138

Equity income (loss) — net
$
602

 
$
819

 
$
690

December 31,
2013

 
2012

Current assets
$
19,229

 
$
16,054

Noncurrent assets
40,427

 
32,687

Total assets
$
59,656

 
$
48,741

Current liabilities
$
14,386

 
$
12,004

Noncurrent liabilities
17,779

 
12,272

Total liabilities
$
32,165

 
$
24,276

Equity attributable to shareowners of investees
$
26,668

 
$
23,827

Equity attributable to noncontrolling interests
823

 
638

Total equity
$
27,491

 
$
24,465

Company equity investment
$
10,393

 
$
9,216

Net sales to equity method investees, the majority of which are located outside the United States, were $9,178 million, $7,082 million and $6,874 million in 2013, 2012 and 2011, respectively. Total payments, primarily marketing, made to equity method investees were $1,807 million, $1,587 million and $1,147 million in 2013, 2012 and 2011, respectively. In addition, purchases of finished products from equity method investees were $415 million, $392 million and $430 million in 2013, 2012 and 2011, respectively.
If valued at the December 31, 2013, quoted closing prices of shares actively traded on stock markets, the value of our equity method investments in publicly traded bottlers would have exceeded our carrying value by $9,155 million.
Net Receivables and Dividends from Equity Method Investees
Total net receivables due from equity method investees were $1,308 million and $1,280 million as of December 31, 2013 and 2012, respectively. The total amount of dividends received from equity method investees was $401 million, $393 million and $421 million for the years ended December 31, 2013, 2012 and 2011, respectively. Dividends received included a $35 million and $60 million special dividend from Coca-Cola Hellenic during 2012 and 2011, respectively. We classified the receipt of these cash dividends in cash flows from operating activities because our cumulative equity in earnings from Coca-Cola Hellenic exceeded the cumulative distributions received; therefore, the dividends were deemed to be a return on our investment and not a return of our investment.